Suspension of trading
Quotes Amicus Therapeutics, Inc.
Stocks
FOLD
US03152W1099
Biotechnology & Medical Research
|
Delayed
Nasdaq
00:00:00 25/04/2026 +04
|
5-day change | 1st Jan Change | ||
| 14.49 USD | +0.21% |
|
-.--% | +1.76% |
| 05-05 | BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says | MT |
| 04-29 | Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index | CI |
Stock exchange
Nasdaq
FOLD 14.49 $
+0.21%
76.58M
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 1 day | +0.21% | ||
| Current year | +1.76% | ||
| 1 year | +63.36% | ||
| 3 years | +45.26% | ||
| 5 years | +28.00% | ||
| 10 years | +67.13% |
Volumes
marketsDaily volume
5,285,334
Estimated daily volume
6,508,621
Record volume 1
188,236,354
Record volume 2
55,625,760
Record volume 3
38,443,411
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
4,549,870,316
Net sales ()
634,210,000
Number of employees
511
Sales / Employee (USD)
1,241,115
Free-Float
99.31%
Free-Float capitalization (USD)
4,518,668,593
Indicators
Moving average 5 days
14.47
Moving average 100 days
13.77
Price spread / (MMA5)
-0.17%
Price spread / (MMA100)
-4.98%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -.--% | +63.36% | +45.26% | 4.55B | |
| +0.01% | +8.40% | +58.48% | +69.01% | 68.22B | |
| +1.22% | +9.56% | +15.97% | +90.23% | 59.82B | |
| +0.24% | +1.35% | +23.78% | +97.55% | 56.07B | |
| +1.15% | +18.96% | +28.29% | +112.10% | 47.67B | |
| -1.34% | +4.73% | +29.09% | +40.33% | 45.95B | |
| -4.38% | -1.34% | +205.47% | +872.20% | 43.29B | |
| -3.33% | +5.73% | +23.28% | +47.32% | 35.66B | |
| -2.19% | -3.71% | +90.94% | +66.33% | 34.73B | |
| +2.05% | +13.13% | -38.44% | +397.47% | 25.47B | |
| Average | -0.67% | +4.83% | +50.02% | +183.78% | 42B | |
| Weighted average by Cap. | -0.64% | +5.35% | +50.20% | +177.61% |
Historical Quotes: Amicus Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| Current year | 14.2 |  | 14.5 |
| 1 year | 8.92 | | 14.5 |
| 3 years | 5.51 | | 14.57 |
| 5 years | 5.51 | | 14.57 |
| 10 years | 4.41 | | 25.39 |
Monthly variations
Annual variations
| 2026 | +1.76% | ||
| 2025 | +51.17% | ||
| 2024 | -33.62% | ||
| 2023 | +16.22% | ||
| 2022 | +5.71% | ||
| 2021 | -49.98% | ||
| 2020 | +137.06% | ||
| 2019 | +1.67% | ||
| 2018 | -33.43% | ||
| 2017 | +189.54% | ||
| 2016 | -48.76% | ||
| 2015 | +16.59% | ||
| 2014 | +254.04% | ||
| 2013 | -12.31% | ||
| 2012 | -22.09% | ||
| 2011 | -26.81% | ||
| 2010 | +18.39% | ||
| 2009 | -50.25% | ||
| 2008 | -25.77% | ||
| 2007 | -25.50% |
- Stock Market
- Stocks
- FOLD Stock
- Quotes Amicus Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
